Panax notoginseng saponins improve oral submucous fibrosis by inhibiting the Wnt/β-catenin signal pathway
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · 2024
DOI: 10.1016/j.oooo.2024.03.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2024. Verfasst von Liang Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Hunan University of Chinese Medicine, Changsha, China; School of Medicine, Hunan University of Chinese Medicine, Changsha, Chi…. Hauptthemen laut MEDLINE: Saponins, Wnt Signaling Pathway, Panax notoginseng, Oral Submucous Fibrosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Oral submucous fibrosis (OSF) is a chronic, insidious, progressive mucosal disease that may be affected by mutations in the Wnt/β-catenin signaling pathway. Panax notoginseng saponins (PNS) is a powerful anti-fibrosis agent; however, its effect and mechanism in treating OSF remain unclear. This study investigated the effect and mechanism of PNS treatment for OSF. STUDY DESIGN: Arecoline was used to induce OSF models in vivo and in vitro, which were then treated with PNS. Hematoxylin-eosin (HE) and Masson trichrome staining were used to observe histopathology changes; E-cadherin and β-catenin were detected by Immunohistochemical assay, and type Ⅰ collagen (CollA1) and β-catenin were detected by immunofluorescent staining. The Wnt/β-catenin pathway and fibrosis signs were assessed using Western Blot and real-time quantitative polymerase chain reaction (RT-qPCR). RESULTS: The expression of CollA1, Wnt1, and β-catenin were increased, and E-cadherin, GSK-3β, and β-catenin expression were decreased in OSF models. PNS and inhibitor intervention increased E-cadherin, Wnt1, and β-catenin and decreased CollA1 and GSK-3β in a dose-dependent manner. CONCLUSION: PNS can improve OSF by inhibiting the Wnt/β-catenin signal pathway and thus may be used as a potential medicine for the treatment of OSF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Stomatology, Hunan University of Chinese Medicine, Changsha, China; School of Medicine, Hunan University of Chinese Medicine, Changsha, China.
- School of Stomatology, Hunan University of Chinese Medicine, Changsha, China; Department of Pharmacy, Changsha Stomatological Hospital, Changsha, China. Electronic address: 540009728@qq.com.
- School of Stomatology, Hunan University of Chinese Medicine, Changsha, China; School of Medicine, Hunan University of Chinese Medicine, Changsha, China. Electronic address: tangqun460@126.com.
Zitieren
APA
Hu, L., He, J., Zhang, T., Pan, S., Zou, H., Lian, K., Guo, J., & Tang, Q. (2024). Panax notoginseng saponins improve oral submucous fibrosis by inhibiting the Wnt/β-catenin signal pathway. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. https://doi.org/10.1016/j.oooo.2024.03.011
Vancouver
Hu L, He J, Zhang T, Pan S, Zou H, Lian K, et al. Panax notoginseng saponins improve oral submucous fibrosis by inhibiting the Wnt/β-catenin signal pathway. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2024. doi:10.1016/j.oooo.2024.03.011
BibTeX
@article{Hu2024,
author = {Hu, Liang and He, Jun and Zhang, Ting and Pan, Shijie and Zou, Hong and Lian, Kequan and Guo, Jincai and Tang, Qun},
title = {Panax notoginseng saponins improve oral submucous fibrosis by inhibiting the Wnt/β-catenin signal pathway},
journal = {Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology},
year = {2024},
doi = {10.1016/j.oooo.2024.03.011}
}
EUVIMED